Literature DB >> 8671214

Fertility treatment and risk of breast cancer.

C Braga1, E Negri, C La Vecchia, F Parazzini, L Dal Maso, S Franceschi.   

Abstract

The relationship between fertility treatment and breast cancer was investigated in a multicentric case-control study conducted in Italy on 2569 women with incident, histologically confirmed breast cancer and 2588 control women admitted to hospitals for acute, non-neoplastic, non-hormonal or gynaecological conditions, unrelated to fertility problems. The odds ratio of breast cancer was 1.08 (95% confidence interval 0.8-1.5) in those reporting fertility treatment compared with those who did not receive fertility treatment. Similarly, the odds ratio was 0.60 for women with tubal occlusion, 0.99 for those reporting hormonal imbalances and 1.32 for other/unspecified reasons. There was no consistent pattern of risk according to age at treatment and time since treatment. Women reporting fertility treatment with drug use had an odds ratio of 1.43, while those who did not report drug therapy had an odds ratio of 0.85. None of these odds ratio estimates was significant. Likewise, there was no heterogeneity among strata of parity, menopausal status, education and family history of breast cancer. Thus, our study, while providing reassuring evidence on the relationship between fertility treatment and breast cancer risk, cannot exclude the possibility that the use of specific drugs may be related to breast carcinogenesis.

Entities:  

Mesh:

Year:  1996        PMID: 8671214     DOI: 10.1093/humrep/11.2.300

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  7 in total

1.  Fertility drugs and young-onset breast cancer: results from the Two Sister Study.

Authors:  Chunyuan Fei; Lisa A Deroo; Dale P Sandler; Clarice R Weinberg
Journal:  J Natl Cancer Inst       Date:  2012-07-06       Impact factor: 13.506

2.  Fertility drugs and the risk of breast and gynecologic cancers.

Authors:  Louise A Brinton; Vikrant V Sahasrabuddhe; Bert Scoccia
Journal:  Semin Reprod Med       Date:  2012-04-27       Impact factor: 1.303

3.  A systematic review and meta-analysis on tubal ligation and breast cancer risk.

Authors:  Nazila Najdi; Arezoo Esmailzadeh; Maryam Shokrpour; Somayeh Nikfar; Seyedeh Zahra Razavi; Mahdi Sepidarkish; Saman Maroufizadeh; Saeid Safiri; Amir Almasi-Hashiani
Journal:  Syst Rev       Date:  2022-06-19

4.  The effect of assisted reproductive technologies on gynecological cancer: report of our experiences and literature review.

Authors:  Mojgan Karimi Zarchi; Mitra Rouhi; Alime H Abdolahi; Seyedhossein Hekmatimoghaddam
Journal:  Int J Biomed Sci       Date:  2013-09

5.  Cytochrome P-450 1B1 Leu432Val Polymorphism Does Not Show Association With Breast Cancer in Northern Iranian Women With a History of Infertility.

Authors:  Maryam Ghanbari Andarieh; Ebrahim Zabihi; Dariush Moslemi; Mouloud Agajani Delavar; Mahmoud Haji-Ahmadi; Ali Shabestani Monfared; Seyed Gholam Ali Jorsaraei; Masoumeh Ghasemi; Sedighe Esmaeilzadeh
Journal:  Biomark Insights       Date:  2017-02-20

Review 6.  Do the Fertility Drugs Increase the Risk of Cancer? A Review Study.

Authors:  Zohre Momenimovahed; Safoura Taheri; Azita Tiznobaik; Hamid Salehiniya
Journal:  Front Endocrinol (Lausanne)       Date:  2019-05-24       Impact factor: 5.555

7.  Association between fertility treatments and breast cancer risk in women with a family history or BRCA mutations: a systematic review and meta-analysis.

Authors:  Xiaojing Liu; Jing Yue; Ruqiya Pervaiz; Hanwang Zhang; Lan Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-13       Impact factor: 6.055

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.